Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft modelsJamunarani Veeraraghavan, Rachel Schiff, Irmina Diala et al.|npj Breast Cancer|2021Cited by 11